Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Journal of Pediatric Hematology/Oncology
|
January 7, 2017
Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma
Michael V Ortiz, Heather Magnan, Emily K Slotkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2006
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M Coughlin, Mark D Fleming, Richard G Carroll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Nature Cancer
|
August 18, 2022
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma
Yun Wei, Qian Qin, Chuan Yan, et al.
Cold Spring Harbor Perspectives in Medicine
|
November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapies
Simone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Molecular Cancer Research : MCR
|
March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Emily K Slotkin, Anita S Bowman, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research
|
October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Journal of Pediatric Hematology/Oncology
|
January 7, 2017
Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma
Michael V Ortiz, Heather Magnan, Emily K Slotkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2006
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M Coughlin, Mark D Fleming, Richard G Carroll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
E Izumchenko, K Paz, D Ciznadija, et al.
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Nature Cancer
|
August 18, 2022
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma
Yun Wei, Qian Qin, Chuan Yan, et al.
Cold Spring Harbor Perspectives in Medicine
|
November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapies
Simone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Molecular Cancer Research : MCR
|
March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Emily K Slotkin, Anita S Bowman, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research
|
October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
JCO Oncology Advances
|
May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Page
of 18